| 1 |
Erlotinib |
1.0 |
Tarceva, RG-1415, CP-358774, OSI-774, Ro-508231, R-1415 |
EGFR |
EGFR signaling
|
| 409 |
eEF2K Inhibitor, A-484954 |
0.210313658516266 |
NA |
eEF2K |
Other, kinases
|
| 408 |
Sphingosine Kinase 1 Inhibitor II |
0.201505189595997 |
PF-543 |
Sphingosine Kinase |
Other, kinases
|
| 1262 |
UNC1215 |
0.192712366203598 |
UNC-1215 |
L3MBTL3 |
Chromatin other
|
| 119 |
Lapatinib |
0.192328956461645 |
Tykerb, Tyverb |
EGFR, ERBB2 |
RTK signaling
|
| 91 |
GSK319347A |
0.19011239550418 |
KIN001-135, IKK-3 inhibitor |
IKK |
Other, kinases
|
| 266 |
Zibotentan |
0.190095527399177 |
ZD4054, ZD-4054 |
Endothelin-1 receptor (EDNRA) |
Other
|
| 447 |
ETP-45835 |
0.188171602001477 |
NA |
MNK1, MNK2 |
Other, kinases
|
| 197 |
Bryostatin 1 |
0.176899411449973 |
Bryostatin |
PKC |
Other
|
| 1114 |
Cetuximab |
0.173491465662313 |
Erbitux, IMC-C225, C225, IMC-225, L01XC06 |
EGFR |
EGFR signaling
|
| 38 |
Saracatinib |
0.171440940904827 |
AZD0530, AZD-0530, AZ-10353926 |
ABL, SRC |
Other, kinases
|
| 186 |
Bexarotene |
0.155691964285714 |
LG-100069, Targretin, Targret, Targrexin, Targretyn, Bexarotenum |
Retinioic X receptor (RXR) agonist |
Other
|
| 202 |
GSK1904529A |
0.154624851131401 |
GSK-1904529A, GSK 1904529A |
IGF1R, IR |
RTK signaling
|
| 1067 |
CCT007093 |
0.151395348837209 |
NA |
PPM1D |
Cell cycle
|
| 59 |
WZ-1-84 |
0.150601546834718 |
KIN001-123 |
BMX |
Other, kinases
|
| 1032 |
Afatinib |
0.14871447902571 |
BIBW2992, Tovok, Gilotrif |
ERBB2, EGFR |
EGFR signaling
|
| 1175 |
Rucaparib |
0.148027807163367 |
PF-01367338, AG-014699, AG-14447, AG-14699 |
PARP1, PARP2 |
Genome integrity
|
| 1377 |
Afatinib |
0.147673347970819 |
BIBW2992, Tovok, Gilotrif |
ERBB2, EGFR |
EGFR signaling
|
| 154 |
CHIR-99021 |
0.147544230261421 |
CT 99021, CHIR99021, CHIR 99021 |
GSK3A, GSK3B |
WNT signaling
|
| 1264 |
SGC0946 |
0.146937427769523 |
NA |
DOT1L |
Chromatin histone methylation
|